Lortholary A, Cossee M, Gamelin E, Larra F
Centre Paul-Papin, Angers, France.
Bull Cancer. 1993 Apr;80(4):280-93.
Although not rare, paraneoplastic syndromes develop in a minority of cancer patients. Their exact frequency seems to be under estimated. These syndromes are hereby described. Their clinical usefulness is of great importance: they can be the first sign of a malignancy and can be used as tumor markers. The diagnosis of paraneoplastic syndromes is often difficult. A "diagnosis score" is proposed to establish this diagnosis easier.